US Patent Issued to NGM Biopharmaceuticals on Sept. 9 for "ILT-binding agents and methods of use thereof" (California Inventors)

ALEXANDRIA, Va., Sept. 10 -- United States Patent no. 12,410,251, issued on Sept. 9, was assigned to NGM Biopharmaceuticals Inc. (South San Francisco, Calif.).

"ILT-binding agents and methods of use thereof" was invented by Dana Yen Mei Duey (San Francisco), Allen James Ebens Jr. (San Carlos, Calif.), Daniel David Kaplan (San Mateo, Calif.), Chia-Ying Kao Lam (South San Francisco, Calif.), Kalyani Mondal (San Mateo, Calif.), Geoffrey William Stone (San Francisco) and Yan Wang (Foster City, Calif.).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present disclosure provides binding agents, such as antibodies, that specifically bind ILT2, ILT4, or both ILT2 and ILT4, as well as compositions comprising the bin...